BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isaacson G, Aronoff SC. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae. International Journal of Pediatric Otorhinolaryngology 2008;72:647-51. [DOI: 10.1016/j.ijporl.2008.01.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Cheng J, Javia L. Methicillin-resistant Staphylococcus aureus (MRSA) pediatric tympanostomy tube otorrhea. International Journal of Pediatric Otorhinolaryngology 2012;76:1795-8. [DOI: 10.1016/j.ijporl.2012.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
2 Garazzino S, Tovo PA. Clinical experience with linezolid in infants and children. J Antimicrob Chemother 2011;66 Suppl 4:iv23-41. [PMID: 21521704 DOI: 10.1093/jac/dkr074] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
3 Yankey H, Isaacson G. Efficacy of topical 2% mupirocin ointment for treatment of tympanostomy tube otorrhea caused by community-acquired methicillin resistant Staphylococcus aureus. International Journal of Pediatric Otorhinolaryngology 2018;109:36-9. [DOI: 10.1016/j.ijporl.2018.03.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Simon A, Müllenborn E, Prelog M, Schenk W, Holzapfel J, Ebinger F, Klabunde-cherwon A, Faber J, Groll AH, Masjosthusmann K, Dohna-schwake C, Beutel K, Dirkwinkel E, Lehrnbecher T, Ammann RA, Müller A. Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter survey. Eur J Clin Microbiol Infect Dis 2012;31:1435-42. [DOI: 10.1007/s10096-011-1461-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chiappini E, Conti C, Galli L, de Martino M. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther 2010;32:66-88. [PMID: 20171414 DOI: 10.1016/j.clinthera.2010.01.019] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
6 Jacobs MR. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008;6:619-35. [PMID: 18847402 DOI: 10.1586/14787210.6.5.619] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
7 Sung CM, Kim HC, Cho YB, Shin SY, Jang CH. Evaluating the ototoxicity of an anti-MRSA peptide KR-12-a2. Braz J Otorhinolaryngol 2018;84:441-7. [PMID: 28625810 DOI: 10.1016/j.bjorl.2017.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
8 Isaacson G. Oxymetazoline, Mupirocin, Clotrimazole-Safe, Effective, Off-Label Agents for Tympanostomy Tube Care. Ear Nose Throat J 2020;99:30S-4S. [PMID: 32182136 DOI: 10.1177/0145561320912885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fishman I, Sykes KJ, Horvat R, Selvarangan R, Newland J, Wei JL. Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy. Otolaryngol Head Neck Surg 2011;145:1025-9. [PMID: 21846926 DOI: 10.1177/0194599811419098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Baugher KM, Hemme TS, Hawkshaw M, Sataloff RT. MRSA otorrhea: A case series and review of the literature. Ear Nose Throat J 2011;90:60-79. [PMID: 21328227 DOI: 10.1177/014556131109000206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]